Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Plus, the BEAT-HIV Delaney project spells out its “three research pillars.”
Even when HIV is fully suppressed, such viral activity may spur persistent immune activation and complicate cure attempts.
A roundup of the major presentations on HIV science at the international conference held July 22 to 28 outlines many exciting developments.
Starting HIV meds within 15 days of infection prevented the development of antibodies.
Treatment with vorinostat, hydroxychloroquine and maraviroc had no effect on viral rebound after an HIV treatment interruption.
The injectable antibody 3BNC117 suppressed HIV and delayed viral rebound for up to 19 weeks in people with the virus who stopped their meds.
“We need drugs that are gentler, kinder, better and cheaper.”
Plus: Lots of women aren’t happy with Sheen as a spokesperson for LELO’s Hex condoms.
The NIH funding will help scientists explore how to “shock and kill” latent HIV reservoirs.
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
Scientists have used the cutting-edge CRISPR/Cas9 gene-editing method to excise a key fragment of HIV’s genetic code from live rodents.
Even when facing potential risks, many people with HIV are quite interested in participating in research of potential cures for the virus.
Yet another study has shown the extreme complexity of the viral reservoir, where HIV hides from ARV treatment, frustrating cure attempts.
“HIV wonk” Hillary says: “We do have the tools to end this epidemic once and for all.”
HIV can become resistant to CRISPR/Cas9 gene editing just as with antiretroviral (ARV) treatment.
A series of media outlets have erroneously reported that scientists may be just three years away from developing a cure for HIV.
Sign in to your POZ Personals account.